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Background: Chronic urticaria (CU) is a multifactorial disease, however, in a majority of patients, it is not possible to ascribe a spe-
ciﬁc aetiology, which is termed ‘idiopathic’. Although autoimmunity has been implicated as a principal cause in 30–50% of these idio-
pathic cases, activation of coagulatory and inﬂammatory cascades has gained attention in last few years.
Aims: To evaluate levels of mean platelet volume, an indicator of platelet activity, in patients with chronic urticaria and determine its
correlation with its severity.
Methods: Mean platelet volume levels were assessed in 194 patients with chronic urticaria and were compared with equal number of
age and sex matched controls. Its levels were also correlated with the severity of urticaria and results of autologous serum skin test.
Result: Mean platelet volume (MPV) levels were found to be higher in patients with ASST positive chronic urticaria compared to
patients with ASST negative chronic urticaria and controls. MPV levels also showed a positive correlation with the severity of chronic
urticaria.
Conclusion: As platelets secrete and express a number of crucial mediators of coagulation and inﬂammation, coagulation and inﬂam-
matory cascades may play a positive role in chronic urticaria, paving the way for better understanding of pathogenesis and introduction
of newer drugs.
 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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The term urticaria is used to dene a disease characterised
by short-lived itchy weals, angio-oedema or both together
(Grattan CEH and Humphreys F on behalf of the British
Association of Dermatologists Therapy Guidelines andhttp://dx.doi.org/10.1016/j.jdds.2014.03.006
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Production and hosting by ElsevierAudit Subcommittee, 2007). When urticaria is present daily
or almost daily for more than 6 weeks, it is called chronic
(Grattan and Kobza Black, 2010).
The causative factor is diﬃcult to identify in chronic urti-
caria. When there is no detectable cause, it is known as
chronic idiopathic urticaria (Champion et al., 1969). Auto-
immunity has been implicated as a principal cause of chronic
urticaria, potentially explaining 30–50% of previously idio-
pathic cases (Asero et al., 2001). A number of other factors
have been implicated including drugs (Grattan, 2003), foods
and food additives (Atkins, 1991), contactants (Williams
et al., 2008), infections (Masood and Imran, 2008; Tebbe
et al., 1996; Varda et al., 1983; Kanazawa et al., 1998;
Serrano, 1975), infestations by intestinal parasites (ChirilaSaud University.
commons.org/licenses/by-nc-nd/3.0/).
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1973; Kobza Black, 1985; Champion, 1988) psychological
factors (Koblenzer, 1983) and other autoimmune diseases.
A highly signiﬁcant linkage of HLA DRB1*04 (DR4) and
its associated allele DQB1*0303 (DR8) with histamine
releasing autoantibody has also been found in chronic urti-
caria (O’Donnel et al., 1999).
Urticaria occurs due to a local increase in permeability of
capillaries and venules. These changes are dependent on acti-
vation of cutaneous mast cells in nearly all types of urticaria
(Grattan et al., 1997)..In autoimmune chronic urticaria, the
participation of various pathogenic autoantibodies, has
been postulated, targetting epitopes on IgE protein itself
or a-chain of its high aﬃnity FceRI receptor, ultimately
causing the release of histamine from mast cells (Fiebiger
et al., 1995). Autologous serum skin test (ASST) is the only
practicable test available to the clinicians to detect autoim-
mune urticaria. Conﬁrmation is needed by in vitro testing
for anti-IgE or FceRIa autoantibodies (Greaves, 2000).
Recent studies demonstrated that activation of a coagu-
lation cascade resulting in thrombin production (Asero
et al., 2007) is a prominent feature of exacerbation of
chronic urticaria. Within the coagulation cascade thrombin
is a serine protease that induces activation of platelets and
may play a key role in chronic urticaria (Lundbland and
White, 2005).
Platelets secrete and express a large number of sub-
stances that are crucial mediators of coagulation, inﬂam-
mation, thrombosis and atherosclerosis. Mean platelet
volume (MPV) is the most commonly used measure of
platelet size and is a potential marker of platelet reactivity
(Coppinger et al., 2004; Gawaz et al., 2005). Studies indi-
cate platelet volume is in direct correlation with platelet
function because large platelets are more reactive. Large
platelets are denser, and produce more thromboxane B2
per unit volume of platelet cytoplasm (Martin et al.,
1983). Several studies report a correlation between high
MPV values and increased disease activity and inﬂamma-
tory markers (Milovanovic et al., 2004; Canpolat et al.,
2010; Yazici et al., 2010; Purnak et al., 2011).2. Materials and methods
This study was a prospective, hospital based, case con-
trolled study conducted on 194 patients of chronic urticariaTable 1
Total urticaria severity score.
Score 0 1
No. of weals None <10
Size of weals None <1cm
Intensity of pruritis None Mild
Duration None <1 h
Frequency of appearance None One in
Frequency of drug intake None Once inattending the outpatient block of the postgraduate depart-
ment of Dermatology, in our hospital.
An informed consent, basic demographic information
and complete history were taken from each patient.
Clinical evaluation of the severity of chronic urticaria
was done in each patient. Severity of chronic urticaria
was calculated from the sum of individual scores (Bajaj
et al., 2008) (Table 1).
An equal number of age and sex matched controls,
attending the Dermatology OPD for insigniﬁcant com-
plaints unrelated to chronic urticaria was taken. Chronic
medical disorders such as diabetes mellitus, hypertension,
autoimmune diseases, liver diseases, malignancies and
intake of medication for the last 3 months were excluded
in history.
All cases and controls underwent a general physical
examination, systemic examination, mucocutaneous exam-
ination and complete blood count with mean platelet vol-
ume in femtolitres (ﬂ) using an automated blood counter,
from a venous sample collected at the time of presentation
with urticarial lesions.
Autologous serum skin test was performed in cases only.
It was performed with 0.05 ml of the patient’s undiluted
serum after blood centrifugation, which was injected intra-
dermally into the volar aspect of the forearm together with
a simultaneously injected equal volume of normal saline as
control at an adjacent site. A red weal with a diameter of
1.5 mm greater than that at control site at 30 min was con-
sidered as positive.2.1. Statistical analysis
Whole data were assimilated in the form of a master
chart. Quantitative data were analysed by using a one way
analysis of variance (ANOVA) and independent sample t-
test. Categorical data were analysed by using the chi-square
test. p-Value of <0.05 was considered signiﬁcant. Data were
subjected to statistical analysis using R-software.3. Results
The age of the patients in the study group ranged from 8
to 70 yrswith amean age of 30.07 yrs ± 3.55.Out of the total
194 patients 72 (37.11%) were males and 122 (62.88%) were
females. Out of a total of 194 patients, 67 patients had a posi-
tive ASST, accounting for 34.53% of the total patients of2 3
11–50 >50
1–3 cm >3 cm
Moderate Severe
1–12 h >12 h
a week 2–3 times per week Daily
a week 2–3 times per week Daily
Table 2
Mean platelet volume in diﬀerent groups.
Group Value (ﬂ) p-Value
ASST+ 12.72667 ± 1.876425 p1 = 0.012 (Sig)
ASST 10.32556 ± 1.898271 p2 = 0.015 (Sig)
Controls 10.01313 ± 2.312550 p3 = 0.194 (NS)
p1, p-Value between ASST+ CU and ASST CU.
p2, p-Value between ASST+ CU and controls.
p3, p-Value between ASST CU and controls.
The diﬀerence in mean platelet volume between the three groups was statistically signiﬁcant.
Table 3
Correlation of severity of chronic urticaria with MPV.
TUSS TUSS MPV
Pearson correlation 1 0.414*
Sig (2-tailed) 0.007
MPV levels showed a positive correlation with severity of chronic
urticaria.
* Correlation is signiﬁcant at the 0.01 level (2-tailed).
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Total urticaria severity score (TUSS) was higher in ASST
positive subjects (12.7607) than in ASST negative ones
(10.2671). The diﬀerence was statistically signiﬁcant
(p = 0.041). The diﬀerence in MPV levels between the cases
with positive ASST, negative ASST and controls was statis-
tically signiﬁcant (Table 2). MPV levels showed a positive
correlation with severity of chronic urticaria (Table 3).
The mean platelet count in ASST positive subjects was
2.04383 ± 1.820685 as compared to 2.04200 ± .647276
and 1.83170 ± .860361 in ASST negative and controls
groups, respectively (Table 4). The count was higher in
ASST positive group as compared to the other two groups
but it had no statistical signiﬁcance (p1 = .994, p2 = .277,
p3 = .327). The correlation between severity and platelet
count was also not statistically signiﬁcant (r = 0.074;
p = 0.454).4. Discussion
Urticaria is a common disease, characterised by distinct
skin reaction pattern, i.e., the development of short-liveditchy weals. Chronic urticaria may be ordinary, physical
or vasculitic, but the term is often considered synonymous
with the ordinary presentation of chronic urticaria. In
some it is not possible to ascertain a speciﬁc aetiology, thus
termed chronic ‘idiopathic’ urticaria. Autoimmunity has
been implicated in a large subset of these patients but it
might not be the only cause. Recent studies support the
involvement of additional pathogenic mechanisms in
patients with chronic urticaria. The activation of a coagu-
latory cascade and systemic inﬂammatory processes has
been investigated and implicated in the pathogenesis of
chronic urticaria.
In our study, mean platelet volume, an indicator of
platelet activity and thus extrinsic coagulation pathway s,
was assessed in all three groups, i.e., cases with a positive
ASST, negative ASST and controls. Higher levels of
MPV were found in ASST positive group (12.72607 ﬂ) as
compared to ASST negative ones (10.32556 ﬂ) and controls
(7.61313 ﬂ). The diﬀerence was statistically signiﬁcant
(p1 = .012, p2 = .015, p3 = .194). There was also a positive
correlation between MPV levels and severity of chronic
urticaria in ASST positive patients (r = 0.414; p = 0.007).
Our results are comparable to that obtained by Magen
E, et al. (2010) who compared MPV in ASST positive, neg-
ative and controls and found MPV of 9.12 ± 1.25 ﬂ in
ASST positive than 7.95 ± 1.08 and 7.72 ± 1.04 ﬂ in ASST
negative and controls, respectively. The results were statis-
tically signiﬁcant between ASST positive and the other two
groups with p values of 0.039, 0.007 and 0.39. There was
also a signiﬁcant positive correlation between the severity
of chronic urticaria and mean platelet volume in ASST
Table 4
Platelet counts in three groups.
Group Value p-Value
ASST+ 2.04383 ± 1.820685 p1 = 0.994 (NS)
ASST 2.04200 ± 0.647276 p2 = 0.277 (NS)
Controls 1.83170 ± 0.860361 p3 = 0.327 (NS)
p1, p-Value between ASST+ CU and ASST CU.
p2, p-Value between ASST+ CU and controls.
p3, p-Value between ASST CU and controls.
The diﬀerence in platelet counts between the three groups was not statistically signiﬁcant.
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negative ones (Magen et al., 2010).
Our results were also comparable to that of Cohen et al.
High mean platelet volume was the most common abnor-
mal laboratory ﬁnding in patients with chronic urticaria.
Out of 12,778 patients with chronic urticaria 3552 had
raised MPV levels. 31% of women and 23% of men had sig-
niﬁcantly higher mean platelet volume as compared to con-
trols (Cohen et al., 2012).
Similar results were seen by Chandrashekar et al. who
observed signiﬁcantly higher mean platelet volume and
platelet distribution width in patients with CU when com-
pared to controls. Urticaria Severity Score correlated pos-
itively with platelet aggregability and soluble P-selectin
levels. APST positive patients had signiﬁcantly higher
platelet aggregation and higher soluble P-selectin levels,
when compared to the APST negative patients, indicating
more platelet activation in the autoimmune group
(Chandrashekar et al., 2014).
The diﬀerence in mean platelet volume observed in our
study cannot be fully explained due to the paucity of litera-
ture on this issue, but it points either towards a direct role
of platelet mediators in the pathogenesis of chronic urticaria
or simply reﬂects bone marrow stimulation, which may be
induced by systemic inﬂammation or as a result of increased
consumption of platelets at the site of urticarial weals.
The assumption that platelet mediators might play a
direct role in the pathogenesis of chronic urticaria, is sup-
ported by the recent reports proposing the activation of a
coagulation cascade in chronic urticaria. Asero et al.
observed that chronic urticaria patients have a positiveautologous plasma skin test (86%) more commonly than
a positive autologous serum skin test (53%) (Asero et al.,
2006). This suggests a possible role of plasma clotting fac-
tors. This was further conﬁrmed by Asero et al. (2008),
Takahagi et al. (2010) and Takeda et al. (2011) who
reported signiﬁcantly elevated mean prothrombin frag-
ments F1+2, factor VIIa and D-dimer levels in patients
of chronic urticaria than in controls. A correlation with
severity was also observed. However, this view was con-
tradicted by Metz et al. who found that skin reactivity to
autologous blood is largely unaﬀected by the presence or
absence of coagulative abnormalities (Metz et al., 2009).
It is thus suggested that platelets might be the activators
of an extrinsic coagulation pathway in these cases and may
in turn inﬂuence the histamine releasing eﬀector cells and
thus the disease and its activity.
Besides coagulation and thrombosis, platelets also pro-
duce a large number of substances that are crucial media-
tors of inﬂammation. Recent studies also report a
correlation between a higher MPV and active inﬂamma-
tory response.
Milovanovic et al. (2004) and Yazici et al. (2010) found
that MPV correlated with disease activity and response to
treatment in rheumatoid arthritis. Canpolat et al. (2010)
found that MPV levels were positively correlated with pso-
riasis area and severity index score and disease duration. It
was also signiﬁcantly increased in those with arthritis than
those without (Canpolat et al., 2010). Purnak et al. found
that MPV correlated with disease activity and remission
on adherence to gluten free diet in coeliac disease
(Purnak et al., 2011).
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spectrum of immune mediated inﬂammatory diseases. The
systemic inﬂammatory response thus associated, induces
bone marrow stimulation and production of larger
platelets.
The possibility of bone marrow stimulation secondary
to increased consumption of platelets at the site of urticar-
ial weals cannot be explained as no signiﬁcant diﬀerences in
platelet counts were observed between the groups.
We hereby conclude that autoimmune urticaria, a clini-
cally more severe disease, is characterised by low-grade
inﬂammation and platelet activation. Thus coagulation
and inﬂammatory cascades may play a positive role in
the pathogenesis of chronic urticaria, paving the way for
better understanding of the disease and introduction of
newer drugs.Conﬂict of interest
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